Sources

Primary Data Sources

RxInsider draws on public regulatory filings, financial disclosures, and government data to inform our coverage. Key sources include:

• SEC EDGAR -- M&A transaction filings, earnings reports, proxy statements
• FDA -- Drug approvals, BLA filings, Orange Book patent data, biosimilar applications
• CMS -- NADAC pricing, Medicare Part D formulary data, Drug Spending Dashboard
• FTC -- PBM investigation reports, merger reviews, competition analysis
• State regulatory filings -- PBM transparency reports, pharmacy benefit legislation

Industry Sources

• Company press releases -- Deal announcements, earnings guidance, pipeline updates
• Clinical trial registries -- ClinicalTrials.gov for pipeline stage verification
• Patent databases -- USPTO, Orange Book for exclusivity and patent cliff analysis